Clinical trial

A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men

NCT01060228

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-01-01

PhasePHASE1

Study timeline

Study start (unknown)2009-01-01Date precision: month

Registry last updated2012-12-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Epilepsyunresolved

Interventions

paliperidone ERDRUG

divalproex sodium ERDRUG

Sponsors & collaborators

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01060228 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.